24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

Resolution Melting technology in the LightCycler 480 . We performed<br />

linkage disequilibrium (LD) and haplotype analysis using the Haploview<br />

and SNPstats programs .<br />

Six <strong>of</strong> the nine polymorphisms initially selected from the public databases<br />

were validated in our population . SSCP/HD analysis allowed<br />

for the identification <strong>of</strong> 9 novel SNPs (3 in TFF1, 4 in TFF2 and 2 in<br />

TFF3), 7 <strong>of</strong> which could be functional, and a novel insertion polymorphism<br />

c .*66_67InsCTT, in the 3’UTR region <strong>of</strong> TFF2. Preliminary LD<br />

analysis indicates that each TFF gene is located in independent LD<br />

blocks and that high LD exists between SNPs in TFF2 . Genotyping<br />

<strong>of</strong> these polymorphisms in case-control studies <strong>of</strong> gastric cancer is at<br />

present underway .<br />

P06.282<br />

investigation <strong>of</strong> genetic component <strong>of</strong> susceptibility to atopic<br />

bronchial asthma and tuberculosis: xenobiotic-metabolising<br />

enzymes.<br />

E. Bragina 1 , M. Freidin 1 , A. Rudko 1 , O. Kolokolova 2 , L. Ogorodova 2 , A. Strelis 2 ,<br />

V. Pusyrev 1 ;<br />

1 Institute <strong>of</strong> Medical <strong>Genetics</strong> <strong>of</strong> Tomsk Scientific Center <strong>of</strong> Siberian Branch <strong>of</strong><br />

Russian Academy <strong>of</strong> Medical Sciences, Tomsk, Russian Federation, 2 Siberian<br />

State Medical University, Tomsk, Russian Federation.<br />

The relationships <strong>of</strong> polymorphic variants <strong>of</strong> the genes encoding xenobiotic-metabolising<br />

enzimes (CYP2C19, CYP2E1, GSTT1, GSTM1,<br />

GSTP1) with atopic bronchial asthma and lung tuberculosis, were studied<br />

in people <strong>of</strong> Tomsk region . An association <strong>of</strong> a deletion polymorphism<br />

<strong>of</strong> the GSTM1 gene and a 7632T>A exchange <strong>of</strong> the CYP2E1<br />

gene with bronchial asthma were revealed (p=0 .008 and p=0 .049, respectively)<br />

. Prevalence <strong>of</strong> a “null” genotype <strong>of</strong> the GSTT1 gene was<br />

significantly different in groups <strong>of</strong> patients with various severity <strong>of</strong> bronchial<br />

asthma (p=0 .045) . It was shown that 313G/G genotype <strong>of</strong> the<br />

GSTP1 gene is a factor <strong>of</strong> resistance to tuberculosis (OR=0 .43; 95%CI:<br />

0 .20-0 .91; p=0 .026) . 681G>A polymorphism <strong>of</strong> the CYP2C19 gene<br />

was associated with scope <strong>of</strong> a pulmonary tissue damage (p=0 .040)<br />

and with amount <strong>of</strong> erythrocytes in tuberculosis patients (p=0 .027) .<br />

313A>G polymorphism <strong>of</strong> the GSTP1 gene was associated with variability<br />

<strong>of</strong> alanine aminotransferase levels (p=0 .021) . The combination<br />

<strong>of</strong> the GSTM1 +/+ and GSTP1 313G/G, played a protective role for the<br />

both studied diseases (OR=0 .10; p=0 .018 for the asthma; OR=0 .37;<br />

p=0 .045 for the tuberculosis) .This suggests that the genotypes and<br />

their combinations <strong>of</strong> CYP2C19, GSTT1, GSTM1 and GSTP1 genes<br />

have influence on predisposition and clinical polymorphisms <strong>of</strong> atopic<br />

asthma and lung tuberculosis .<br />

P06.283<br />

Sex-specific genetic determinants in plasma levels <strong>of</strong> fibrinogen<br />

M. Sabater-Lleal 1 , A. Buil 2 , J. Souto 1 , L. Almasy 3 , J. Blangero 3 , J. Fontcuberta 1 ,<br />

J. Soria 1,2 ;<br />

1 Haemostasis and Thrombosis Unit, Department <strong>of</strong> Hematology, <strong>Barcelona</strong>,<br />

Spain, 2 Bioinformatic <strong>of</strong> Complex Diseases Unit. Research Institute <strong>of</strong> Hospital<br />

de la Santa Creu i Sant Pau, <strong>Barcelona</strong>, Spain, 3 Department <strong>of</strong> Population<br />

<strong>Genetics</strong>. Southwest Foundation for Biomedical Research, San Antonio, TX,<br />

United States.<br />

A major challenge <strong>of</strong> biomedical research is the identification <strong>of</strong> risk<br />

factors for complex diseases . One well-established risk factor for cardiovascular<br />

disease is the plasma fibrinogen levels. These levels are<br />

influenced largely by genetic factors. But the exact nature <strong>of</strong> these<br />

genetic factors is unknown .<br />

Our aim was to localize QTL responsible for the plasma levels <strong>of</strong> fibrinogen<br />

. We present the results <strong>of</strong> a Genome Wide Scan for fibrinogen<br />

levels that includes a gender-specific analysis in 21 Spanish families<br />

from the GAIT (Genetic Analysis <strong>of</strong> Idiopathic Thrombophilia) Project .<br />

We used 500 DNA microsatellites scattered throughout the genome .<br />

Our results revealed a highly significant LOD score (3.52, nominal<br />

p=0 .00003) on Chromosome 17 that was only detected in females, indicating<br />

that a QTL on this chromosome was responsible for fibrinogen<br />

levels only in women .<br />

A bioinformatic study in the region <strong>of</strong> Chromosome 17 revealed the<br />

presence <strong>of</strong> some hormone-related genes (steroid hormone receptors)<br />

that affect fibrinogen levels and that could explain this gender-specific<br />

finding.<br />

To our knowledge, this is the first report <strong>of</strong> a gender-specific QTL related<br />

to cardiovascular disease. It demonstrates that a gender-specific<br />

genetic analysis can increase our ability to detect phenotypes that are<br />

affected by sex . We hope that our results will help to understand the<br />

regulation <strong>of</strong> fibrinogen plasma levels that determine the susceptibility<br />

<strong>of</strong> cardiovascular disease . Our results may provide a template for future<br />

genetic studies <strong>of</strong> quantitative traits affecting complex diseases .<br />

P06.284<br />

Genetic variants <strong>of</strong> the tBX15 gene associated with thyroid<br />

cancer susceptibility<br />

M. Akdi1 , P. Gal<strong>of</strong>ré2 , R. Marcos1 , A. Velázquez1 ;<br />

1 2 Universitat Autònoma de <strong>Barcelona</strong> and CIBERESP, Cerdanyola, Spain, Hospital<br />

Josep Trueta, Girona, Spain.<br />

Association studies to identify susceptibility genetic factors for thyroid<br />

cancer have been appeared recently . Our initial case-control association<br />

studies had shown that the rs2145418 and the rs4658973 markers<br />

that map 377 kb apart on the 1p12 region have an independent<br />

association with thyroid cancer susceptibility . Next we have expanded<br />

these initial studies by genotype and haplotype analysis in the region<br />

containing the two markers . Here we present the results related to the<br />

rs2145418 region . Thus, the MassArray technique was used to genotype<br />

136 control individuals and 201 thyroid patients . First we have<br />

confirmed our previous results, by genotyping the rs2145418 SNP<br />

along with two SNPs surrounding this marker . Only the rs2145418<br />

polymorphism showed association with thyroid cancer . Consequently,<br />

our hypothesis that rs2145418 could reside in a regulatory sequence<br />

<strong>of</strong> casual genes mapping near or at certain distance <strong>of</strong> this marker<br />

can not discarded . In addition, we have studied nine SNPs that cover<br />

the TBX15 gene sequence, this gene maps 550 kb downstream <strong>of</strong><br />

rs2145418 . Four <strong>of</strong> these SNPs lying on the 5’-UTR region have shown<br />

significant association with thyroid cancer (pT<br />

<strong>of</strong> CD14 gene in 157 blood samples from children admitted in the Critical<br />

Care Unit <strong>of</strong> the Hospital Niño Jesus (Madrid) with meningococcal<br />

(Gram-negative) (n=55) or pneumococcal (Gram-positive) (n=102)<br />

infections . Sixty six controls were genotyped in order to compare the<br />

genotypic frequencies .<br />

Genotypic frequencies <strong>of</strong> TLR2 polymorphisms were clearly different<br />

in both groups <strong>of</strong> patients, when compared to control population, especially<br />

for the p .R753Q polymorphism, being more frequent the p .753Q<br />

allele (p=0 .0004 in meningococcal infections, and p=0 .0005 in pneumococcal<br />

infections) .<br />

Conversely, TLR4 polymorphism din not show different genotypic distribution<br />

when compared to control population . Finally, the study <strong>of</strong> the<br />

polymorphism <strong>of</strong> the CD14 showed different distribution when compared<br />

to controls, with a p=0 .0113 in meningococcal infections and<br />

p=0 .0353 in pneumococcal infections .<br />

No differences were found among both groups <strong>of</strong> studied patients .<br />

These results confirm the key role <strong>of</strong> the innate immunity system in predisposition<br />

to severe infections . For both studied bacteria, the main risk<br />

factor is the p .753Q allele followed by the CD14 promoter polymorphism .<br />

TLR4 polymorphism did not influence the risk <strong>of</strong> suffering infections.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!